Viewing Study NCT05105867


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-03-14 @ 8:37 AM
Study NCT ID: NCT05105867
Status: UNKNOWN
Last Update Posted: 2023-05-10
First Post: 2021-10-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies
Sponsor: 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module